Newly unveiled court documents show that ghostwriters paid by a pharmaceutical company played a major role in producing 26 scientific papers backing the use of hormone replacement therapy in women. The findings suggest that the level of hidden industry influence on medical literature is broader than previously known, according to the New York Times.